<p>Pediatrix Medical Group, Inc. (NYSE:MD - 获取免费报告) 的股价在周四的交易中下跌了 3.5%，原因是内部人士出售股票。该公司股价最低跌至 22.14 美元，最后交易价格为 21.7650 美元。在交易中，共成交 42,312 股，较平均交易量 803,766 股下降了 95%。该股票此前收盘价为 22.56 美元。</p>
<ul>
<li>美敦力股票找到支撑——现在正在获得动能</li>
</ul>
<p>具体来说，首席执行官马克·S·奥尔丹在 12 月 15 日（星期一）出售了 23,000 股公司的股票。股票以平均价格 22.41 美元出售，总交易额为 515,430.00 美元。交易后，首席执行官持有 302,805 股公司的股票，价值约为 6,785,860.05 美元。这笔交易代表了他们持股比例的 7.06% 的减少。该出售在与证券交易委员会的法律文件中披露，相关信息可通过 SEC 网站获取。</p>
<h2>分析师评级升级与降级</h2>
<p>几家券商对 MD 发表了评论。瑞银集团在 11 月 5 日的研究报告中将 Pediatrix Medical Group 的目标股价从 16.50 美元上调至 23.00 美元，并给予该公司 “中性” 评级。Weiss Ratings 在周一的研究报告中重申了对 Pediatrix Medical Group 的 “持有（c+）” 评级。华尔街 Zen 在 10 月 4 日的报告中将 Pediatrix Medical Group 的评级从 “买入” 上调至 “强力买入”。Truist Financial 在 11 月 10 日的研究报告中将 Pediatrix Medical Group 的目标股价从 17.00 美元上调至 24.00 美元，并给予该公司 “持有” 评级。最后，Zacks Research 在 11 月 21 日的报告中将 Pediatrix Medical Group 的评级从 “持有” 上调至 “强力买入”。一位分析师给予该股票 “强力买入” 评级，一位给予 “买入” 评级，四位给予 “持有” 评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 21.00 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
<p><strong>获取我们最新的 MD 股票报告</strong></p>
<h2>Pediatrix Medical Group 股票表现</h2>
<p>该公司的市值为 18.5 亿美元，市盈率为 11.48，贝塔值为 0.77。该公司的速动比率为 1.83，流动比率为 1.83，债务股本比率为 0.65。该股票的 50 日移动平均价格为 20.73 美元，200 日移动平均价格为 16.92 美元。</p>
<ul>
<li>美敦力：收入投资者的机会变得更健康</li>
</ul>
<p>Pediatrix Medical Group (NYSE:MD - 获取免费报告) 最近在 11 月 3 日（星期一）发布了其财报。该公司报告本季度每股收益为 0.67 美元，超出市场共识预期的 0.46 美元，超出幅度为 0.21 美元。该业务本季度的收入为 4.9288 亿美元，而分析师预期为 4.7645 亿美元。Pediatrix Medical Group 的净利润率为 8.44%，股本回报率为 20.45%。该业务的季度收入同比下降了 3.6%。在去年同期，该业务的每股收益为 0.44 美元。分析师预计 Pediatrix Medical Group, Inc.在当前财政年度将发布 1.38 美元的每股收益。</p>
<h2>机构投资者对 Pediatrix Medical Group 的看法</h2>
<p>几家对冲基金和其他机构投资者最近增加或减少了对该公司的持股。Smartleaf Asset Management LLC 在第三季度将其在 Pediatrix Medical Group 的持股比例提高了 10.6%。Smartleaf Asset Management LLC 现在拥有 6,250 股该公司的股票，价值 101,000 美元，此前在上个季度又购买了 601 股。PNC 金融服务集团在第三季度将其在 Pediatrix Medical Group 的持股比例提高了 4.5%。PNC 金融服务集团现在拥有 14,525 股该公司的股票，价值 243,000 美元，此前在此期间又购买了 631 股。Gotham Asset Management LLC 在第三季度将其在 Pediatrix Medical Group 的持股比例提高了 0.6%。Gotham Asset Management LLC 现在拥有 116,093 股该公司的股票，价值 1,945,000 美元，此前在上个季度又购买了 724 股。AlphaQuest LLC 在第一季度将其在 Pediatrix Medical Group 的持股比例提高了 16.0%。AlphaQuest LLC 现在拥有 5,877 股该公司的股票，价值 85,000 美元，此前在上个季度又购买了 811 股。最后，Amalgamated Bank 在第三季度将其在 Pediatrix Medical Group 的持股比例提高了 3.5%。Amalgamated Bank 现在拥有 24,891 股该公司的股票，价值 417,000 美元，此前在上个季度又购买了 831 股。目前 97.71% 的股票由机构投资者和对冲基金持有。</p>
<h2>关于 Pediatrix Medical Group</h2>
<p>(获取免费报告)</p>
<p>Pediatrix Medical Group, Inc.及其子公司在美国提供新生儿、母胎、儿科心脏病学及其他儿科专科护理服务。它提供新生儿护理服务，例如通过新生儿医生专科医生、新生儿护士执业者和其他儿科临床医生在医院特定病房内对早产或有并发症的婴儿进行临床护理。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票比 Pediatrix Medical Group 更好</li>
<li>你应该投资于便士股票吗？</li>
<li>2026 年可能会反弹的三只新年决心股票</li>
<li>工业产品股票投资</li>
<li>大麻股票反转：幻想还是机会？</li>
<li>罗素 2000 指数，投资者如何利用它进行盈利交易</li>
<li>降息使这三只收入 ETF 比以往更具吸引力</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 $1,000 在 Pediatrix Medical Group 吗？</h2>
<p>在考虑 Pediatrix Medical Group 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Pediatrix Medical Group 并不在名单上。</p>
<p>虽然 Pediatrix Medical Group 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Pediatrix Medical Group 的股价在首席执行官 Mark S. Ordan 出售 23,000 股后下跌了 3.5%。该股最低交易价为 22.14 美元，交易量显著下降。分析师的评级不一，有些将该股评级上调至 “强烈买入”。公司报告的收益超出预期，净利润率为 8.44%，股本回报率为 20.45%。机构投资者持有 97.71% 的股份</p>

<p>Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report)'s stock price traded down 3.5% during trading on Thursday following insider selling activity. The company traded as low as $22.14 and last traded at $21.7650. 42,312 shares traded hands during trading, a decline of 95% from the average session volume of 803,766 shares. The stock had previously closed at $22.56.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc. (NYSE:MD - 获取免费报告) 的股价在周四的交易中下跌了 3.5%，原因是内部人士出售股票。该公司股价最低跌至 22.14 美元，最后交易价格为 21.7650 美元。在交易中，共成交 42,312 股，较平均交易量 803,766 股下降了 95%。该股票此前收盘价为 22.56 美元。</p>
</div><ul>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力股票找到支撑——现在正在获得动能</li>
</ul>
</div><p>Specifically, CEO Mark S. Ordan sold 23,000 shares of the firm's stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $22.41, for a total transaction of $515,430.00. Following the transaction, the chief executive officer owned 302,805 shares of the company's stock, valued at approximately $6,785,860.05. This trade represents a 7.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through the SEC website.</p>
<div class="lb-trans"><p>具体来说，首席执行官马克·S·奥尔丹在 12 月 15 日（星期一）出售了 23,000 股公司的股票。股票以平均价格 22.41 美元出售，总交易额为 515,430.00 美元。交易后，首席执行官持有 302,805 股公司的股票，价值约为 6,785,860.05 美元。这笔交易代表了他们持股比例的 7.06% 的减少。该出售在与证券交易委员会的法律文件中披露，相关信息可通过 SEC 网站获取。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级升级与降级</h2>
</div><p>Several brokerages have commented on MD. UBS Group upped their target price on shares of Pediatrix Medical Group from $16.50 to $23.00 and gave the company a &#34;neutral&#34; rating in a research report on Wednesday, November 5th. Weiss Ratings reiterated a &#34;hold (c+)&#34; rating on shares of Pediatrix Medical Group in a research report on Monday. Wall Street Zen raised Pediatrix Medical Group from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a report on Saturday, October 4th. Truist Financial lifted their price target on Pediatrix Medical Group from $17.00 to $24.00 and gave the company a &#34;hold&#34; rating in a research report on Monday, November 10th. Finally, Zacks Research upgraded Pediatrix Medical Group from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a report on Friday, November 21st. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $21.00.</p>
<div class="lb-trans"><p>几家券商对 MD 发表了评论。瑞银集团在 11 月 5 日的研究报告中将 Pediatrix Medical Group 的目标股价从 16.50 美元上调至 23.00 美元，并给予该公司 “中性” 评级。Weiss Ratings 在周一的研究报告中重申了对 Pediatrix Medical Group 的 “持有（c+）” 评级。华尔街 Zen 在 10 月 4 日的报告中将 Pediatrix Medical Group 的评级从 “买入” 上调至 “强力买入”。Truist Financial 在 11 月 10 日的研究报告中将 Pediatrix Medical Group 的目标股价从 17.00 美元上调至 24.00 美元，并给予该公司 “持有” 评级。最后，Zacks Research 在 11 月 21 日的报告中将 Pediatrix Medical Group 的评级从 “持有” 上调至 “强力买入”。一位分析师给予该股票 “强力买入” 评级，一位给予 “买入” 评级，四位给予 “持有” 评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 21.00 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
</div><p><strong>Get Our Latest Stock Report on MD</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的 MD 股票报告</strong></p>
</div><h2>Pediatrix Medical Group Stock Performance</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 股票表现</h2>
</div><p>The firm has a market cap of $1.85 billion, a price-to-earnings ratio of 11.48 and a beta of 0.77. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.65. The stock has a fifty day moving average price of $20.73 and a 200-day moving average price of $16.92.</p>
<div class="lb-trans"><p>该公司的市值为 18.5 亿美元，市盈率为 11.48，贝塔值为 0.77。该公司的速动比率为 1.83，流动比率为 1.83，债务股本比率为 0.65。该股票的 50 日移动平均价格为 20.73 美元，200 日移动平均价格为 16.92 美元。</p>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投资者的机会变得更健康</li>
</ul>
</div><p>Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its earnings results on Monday, November 3rd. The company reported $0.67 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.21. The business had revenue of $492.88 million for the quarter, compared to analyst estimates of $476.45 million. Pediatrix Medical Group had a net margin of 8.44% and a return on equity of 20.45%. The business's quarterly revenue was down 3.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.44 EPS. On average, analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Pediatrix Medical Group (NYSE:MD - 获取免费报告) 最近在 11 月 3 日（星期一）发布了其财报。该公司报告本季度每股收益为 0.67 美元，超出市场共识预期的 0.46 美元，超出幅度为 0.21 美元。该业务本季度的收入为 4.9288 亿美元，而分析师预期为 4.7645 亿美元。Pediatrix Medical Group 的净利润率为 8.44%，股本回报率为 20.45%。该业务的季度收入同比下降了 3.6%。在去年同期，该业务的每股收益为 0.44 美元。分析师预计 Pediatrix Medical Group, Inc.在当前财政年度将发布 1.38 美元的每股收益。</p>
</div><h2>Institutional Investors Weigh In On Pediatrix Medical Group</h2>
<div class="lb-trans"><h2>机构投资者对 Pediatrix Medical Group 的看法</h2>
</div><p>Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Smartleaf Asset Management LLC raised its position in shares of Pediatrix Medical Group by 10.6% in the third quarter. Smartleaf Asset Management LLC now owns 6,250 shares of the company's stock valued at $101,000 after buying an additional 601 shares in the last quarter. PNC Financial Services Group Inc. grew its position in shares of Pediatrix Medical Group by 4.5% in the 3rd quarter. PNC Financial Services Group Inc. now owns 14,525 shares of the company's stock worth $243,000 after buying an additional 631 shares during the period. Gotham Asset Management LLC boosted its position in Pediatrix Medical Group by 0.6% in the third quarter. Gotham Asset Management LLC now owns 116,093 shares of the company's stock worth $1,945,000 after purchasing an additional 724 shares during the last quarter. AlphaQuest LLC grew its position in shares of Pediatrix Medical Group by 16.0% during the first quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock valued at $85,000 after purchasing an additional 811 shares in the last quarter. Finally, Amalgamated Bank grew its stake in Pediatrix Medical Group by 3.5% in the 3rd quarter. Amalgamated Bank now owns 24,891 shares of the company's stock worth $417,000 after acquiring an additional 831 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>几家对冲基金和其他机构投资者最近增加或减少了对该公司的持股。Smartleaf Asset Management LLC 在第三季度将其在 Pediatrix Medical Group 的持股比例提高了 10.6%。Smartleaf Asset Management LLC 现在拥有 6,250 股该公司的股票，价值 101,000 美元，此前在上个季度又购买了 601 股。PNC 金融服务集团在第三季度将其在 Pediatrix Medical Group 的持股比例提高了 4.5%。PNC 金融服务集团现在拥有 14,525 股该公司的股票，价值 243,000 美元，此前在此期间又购买了 631 股。Gotham Asset Management LLC 在第三季度将其在 Pediatrix Medical Group 的持股比例提高了 0.6%。Gotham Asset Management LLC 现在拥有 116,093 股该公司的股票，价值 1,945,000 美元，此前在上个季度又购买了 724 股。AlphaQuest LLC 在第一季度将其在 Pediatrix Medical Group 的持股比例提高了 16.0%。AlphaQuest LLC 现在拥有 5,877 股该公司的股票，价值 85,000 美元，此前在上个季度又购买了 811 股。最后，Amalgamated Bank 在第三季度将其在 Pediatrix Medical Group 的持股比例提高了 3.5%。Amalgamated Bank 现在拥有 24,891 股该公司的股票，价值 417,000 美元，此前在上个季度又购买了 831 股。目前 97.71% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>About Pediatrix Medical Group</h2>
<div class="lb-trans"><h2>关于 Pediatrix Medical Group</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc.及其子公司在美国提供新生儿、母胎、儿科心脏病学及其他儿科专科护理服务。它提供新生儿护理服务，例如通过新生儿医生专科医生、新生儿护士执业者和其他儿科临床医生在医院特定病房内对早产或有并发症的婴儿进行临床护理。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Pediatrix Medical Group</li>
<li>Should You Invest in Penny Stocks?</li>
<li>3 New Year’s Resolution Stocks That Could Turn Around in 2026</li>
<li>Industrial Products Stocks Investing</li>
<li>Cannabis Stocks Up for Reversal: Pipedreams or Opportunity?</li>
<li>Russell 2000 Index, How Investors Use it For Profitable Trading</li>
<li>Rate Cuts Make These 3 Income ETFs More Attractive Than Ever</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Pediatrix Medical Group 更好</li>
<li>你应该投资于便士股票吗？</li>
<li>2026 年可能会反弹的三只新年决心股票</li>
<li>工业产品股票投资</li>
<li>大麻股票反转：幻想还是机会？</li>
<li>罗素 2000 指数，投资者如何利用它进行盈利交易</li>
<li>降息使这三只收入 ETF 比以往更具吸引力</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Pediatrix Medical Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Pediatrix Medical Group 吗？</h2>
</div><p>Before you consider Pediatrix Medical Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Pediatrix Medical Group 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Pediatrix Medical Group 并不在名单上。</p>
</div><p>While Pediatrix Medical Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Pediatrix Medical Group 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Pediatrix Medical Group（NYSE:MD）在内部人士抛售后股价下跌 3.5%